Patrick M Sweeney & Associates Inc. Invests $1.03 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Patrick M Sweeney & Associates Inc. bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,948 shares of the healthcare conglomerate’s stock, valued at approximately $1,025,000. UnitedHealth Group makes up about 0.9% of Patrick M Sweeney & Associates Inc.’s holdings, making the stock its 25th biggest holding.

Other hedge funds have also recently modified their holdings of the company. Bray Capital Advisors boosted its holdings in shares of UnitedHealth Group by 0.5% in the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after acquiring an additional 50 shares during the period. Brown Advisory Inc. raised its position in UnitedHealth Group by 6.9% in the third quarter. Brown Advisory Inc. now owns 2,412,908 shares of the healthcare conglomerate’s stock worth $1,216,564,000 after acquiring an additional 156,068 shares in the last quarter. Wealth Management Partners LLC boosted its holdings in UnitedHealth Group by 10.1% during the third quarter. Wealth Management Partners LLC now owns 2,860 shares of the healthcare conglomerate’s stock worth $1,442,000 after buying an additional 262 shares in the last quarter. Jessup Wealth Management Inc grew its holdings in UnitedHealth Group by 4.6% during the 3rd quarter. Jessup Wealth Management Inc now owns 6,610 shares of the healthcare conglomerate’s stock valued at $3,333,000 after buying an additional 291 shares during the last quarter. Finally, Segment Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 4.7% during the 3rd quarter. Segment Wealth Management LLC now owns 28,095 shares of the healthcare conglomerate’s stock worth $14,165,000 after purchasing an additional 1,270 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Up 0.4 %

Shares of UnitedHealth Group stock traded up $2.25 on Wednesday, reaching $503.21. 2,922,430 shares of the company were exchanged, compared to its average volume of 4,361,874. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The stock has a fifty day moving average price of $481.45 and a 200-day moving average price of $511.98. The firm has a market capitalization of $462.99 billion, a price-to-earnings ratio of 30.62, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter last year, the firm posted $6.26 earnings per share. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. On average, analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.49%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Barclays upped their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Stephens reiterated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. Truist Financial reiterated a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a research note on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.